Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma
Palam, L R, Gore, J, Craven, K E, Wilson, J L, Korc, M
Published in Cell death & disease (01.10.2015)
Published in Cell death & disease (01.10.2015)
Get full text
Journal Article
Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases
Ueda, J, Matsuda, Y, Yamahatsu, K, Uchida, E, Naito, Z, Korc, M, Ishiwata, T
Published in Oncogene (04.09.2014)
Published in Oncogene (04.09.2014)
Get full text
Journal Article
Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer
Friess, H, Ding, J, Kleeff, J, Fenkell, L, Rosinski, J A, Guweidhi, A, Reidhaar-Olson, J F, Korc, M, Hammer, J, Büchler, M W
Published in Cellular and molecular life sciences : CMLS (01.06.2003)
Published in Cellular and molecular life sciences : CMLS (01.06.2003)
Get full text
Journal Article
Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma
Pipas, J.M., Zaki, B.I., McGowan, M.M., Tsapakos, M.J., Ripple, G.H., Suriawinata, A.A., Tsongalis, G.J., Colacchio, T.A., Gordon, S.R., Sutton, J.E., Srivastava, A., Smith, K.D., Gardner, T.B., Korc, M., Davis, T.H., Preis, M., Tarczewski, S.M., MacKenzie, T.A., Barth, R.J.
Published in Annals of oncology (01.11.2012)
Published in Annals of oncology (01.11.2012)
Get full text
Journal Article
Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders
Zhu, Z-W, Friess, H, Wang, L, Abou-Shady, M, Zimmermann, A, Lander, A D, Korc, M, Kleeff, J, Büchler, M W
Published in Gut (01.04.2001)
Published in Gut (01.04.2001)
Get full text
Journal Article
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer
Kleeff, J, Ishiwata, T, Kumbasar, A, Friess, H, Büchler, M W, Lander, A D, Korc, M
Published in The Journal of clinical investigation (01.11.1998)
Published in The Journal of clinical investigation (01.11.1998)
Get full text
Journal Article
RB loss in conjunction with oncogenic Kras causes perturbations in TGF-β signaling and upregulates AGR2 expression
Gore, A.J, Norris, A.M, Korc, M
Published in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] (01.03.2013)
Published in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] (01.03.2013)
Get full text
Journal Article
The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer
KLEEFF, J, ISHIWATA, T, MARUYAMA, H, FRIESS, H, TRUONG, P, BÜCHLER, M. W, FALB, D, KORC, M
Published in Oncogene (23.09.1999)
Published in Oncogene (23.09.1999)
Get full text
Journal Article
Activated K-Ras and INK4a/Arf Deficiency Promote Aggressiveness of Pancreatic Cancer by Induction of EMT Consistent With Cancer Stem Cell Phenotype
Wang, Z., Ali, S., Banerjee, S., Bao, B., Li, Y., Azmi, A.S., Korc, M., Sarkar, F.H.
Published in Journal of cellular physiology (01.08.2014)
Published in Journal of cellular physiology (01.08.2014)
Get full text
Journal Article
Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma
CANTERO, D, FRIESS, H, DEFLORIN, J, ZIMMERMANN, A, BRÜNDLER, M.-A, RIESLE, E, KORC, M, BÜCHLER, M. W
Published in British journal of cancer (01.01.1997)
Published in British journal of cancer (01.01.1997)
Get full text
Journal Article
Syndecan‐1 expression is up‐regulated in pancreatic but not in other gastrointestinal cancers
Conejo, J.R., Kleeff, J., Koliopanos, A., Matsuda, K., Zhu, Z.W., Goecke, H., Bicheng, N., Zimmermann, A., Korc, M., Friess, H., Büchler, M.W.
Published in International journal of cancer (01.10.2000)
Published in International journal of cancer (01.10.2000)
Get full text
Journal Article